Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Actuarialon Aug 31, 2018 3:21pm
213 Views
Post# 28550567

RE:RE:RE:RE:NR: Antibe Provides Scientific Report on ATB-346

RE:RE:RE:RE:NR: Antibe Provides Scientific Report on ATB-346Two thoughts,

1. COX supression is not as legitimate as WOMAC score being a pain relief measure. For example, cannabis or opoid pain killers work through a different path. H2S helps ATB346 outperform naproxen in pain reflief might not by COX supression. That's why Characterization of Metabolites step becomes important.

2. 
mild transient elevations of liver transaminases is nothing uncommon after medications. Adverse serious event is something what FDA concerns. Other than that, it is called safe and well tolerated.

 

Table 1.

Causes of Elevated Liver Transaminase Levels, Clinical Clues, and Initial Diagnostic Testing

ETIOLOGY CLINICAL CLUES INITIAL DIAGNOSTIC TESTING

Common

Alcohol-related

Excessive alcohol consumption

Aspartate transaminase/alanine transaminase ratio, γ-glutamyl transpeptidase level

Hemochromatosis

Family history

Serum iron and ferritin levels, total iron-binding capacity

Hepatitis B

Immigration from endemic countries, nonmonogamous sexual activity, injection drug use

Hepatitis B surface antigen testing

Hepatitis C

Injection drug use, human immunodeficiency virus infection, blood transfusion before 1992

Hepatitis C virus antibody testing

Medications

Polypharmacy, certain herbal preparations

History

Nonalcoholic fatty liver disease

Evidence of metabolic syndrome (high triglyceride levels, low high-density lipoprotein levels, increased waist circumference, elevated glucose levels)

Fasting lipid profile, glucose level; consider ultrasonography

Less common

α1-antitrypsin deficiency

Early-onset emphysema, family history

Serum α1-antitrypsin level

Autoimmune hepatitis

Women with autoimmune disorders

Serum protein electrophoresis; antibodies to liver/kidney microsomal antibody type 1, antinuclear antibody, and smooth muscle antibody testing

Wilson disease

Younger than 40 years, neuropsychiatric symptoms, Kayser-Fleischer rings

Serum ceruloplasmin level

Extrahepatic

Celiac disease

Diarrhea, abdominal pain, malabsorption

Tissue transglutaminase antibody testing

Hemolysis

Glucose-6-phosphate dehydrogenase deficiency, sickle cell anemia, infection

Lactate dehydrogenase and haptoglobin levels, reticulocyte count

Muscular disorders

Muscle weakness and pain, strenuous exercise

Creatine kinase and aldolase levels


Bullboard Posts